Follicular Lymphoma Market to Expand at a Significant Growth Rate During the Forecast Period (2023-32) - Estimates DelveInsight | Incyte, Genmab, BeiGene, Merck, ADC Therapeutics, Xynomic, Allogene, Innovent, Nordic Nanovector, TG Therapeutics

Follicular Lymphoma Market size in the seven major markets was USD 1,451 million in 2020, which is expected to grow by 2032. As per DelveInsight, the Follicular Lymphoma Market is anticipated to evolve immensely in the coming years owing to the rise in the number of cases of Follicular Lymphoma and the launch of new therapies in the market.

DelveInsight's "Follicular Lymphoma Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Follicular Lymphoma Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The market report covers emerging drugs, treatment practices, market share of individual Follicular Lymphoma therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Follicular Lymphoma treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Follicular Lymphoma: An Overview
As per the Leukemia & Lymphoma Society, Non-Hodgkin Lymphoma (NHL) is a type of cancer that generally develops in the lymph nodes and lymphatic tissue found in organs such as the stomach, intestines, or skin. In some cases, the NHL involves bone marrow and blood. NHL is classified based on the type of lymphocyte involved: B lymphocytes (B cells), T lymphocytes (T-cells), and Natural killer cells. NHL can also be indolent (slow progression) or aggressive (rapid progression).

According to the Lymphoma Research Foundation, Follicular Lymphoma (FL) is a slow-growing or indolent form of non-Hodgkin lymphoma (NHL) that arises from B-lymphocytes. This lymphoma subtype accounts for 20-30% of all NHL Cases. FL is usually a slow-growing (indolent) lymphoma, although some FL can grow rapidly.

Follicular Lymphoma Market Key Facts
• The incident population of Follicular Lymphoma in the 7MM countries was estimated to be 35,737 cases in 2020.
• According to a study by Center for International Blood and Marrow Transplant Research estimates that among patients with follicular lymphoma who are potential transplant candidates, fewer than 5% actually undergo transplantation. This accounts to about 150 to 200 auto-transplants a year in the US.
• A study conducted by Mozas et al. (2020), titled "Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience," shows that 54% FL patients were refractory or experienced relapse/progression during follow-up.
• As per the study by Fujishima et al. (2018), titled "Incidence Rate, Subtype Frequency, and Occurrence Site of Malignant Lymphoma in the Gastrointestinal Tract: Population-Based Analysis in Miyagi, Japan," the incidence of FL in Japan was 2.80 per 100,000 persons.
• According to a study by Kanas et al. (2021), the incidence Cases of FL are approximately 3,300, 2,900, 2,800, 1,700, and 2,800 in Germany, France, Italy, Spain, and the UK respectively.

Discover How Follicular Lymphoma Market Will Grow by 2032:
https://www.delveinsight.com/report-store/follicular-lymphoma-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Follicular Lymphoma Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Follicular Lymphoma therapies in the market. It also provides a detailed assessment of the Follicular Lymphoma market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the market trend for each marketed Follicular Lymphoma drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Follicular Lymphoma Epidemiology
The epidemiology section covers detailed insights into the historical, and current Follicular Lymphoma patient pool and forecasted epidemiology trends for every seven major countries (7MM) from 2019 to 2032.

The Report Covers the Follicular Lymphoma Epidemiology Segmented as -
• Total Incident Cases of FL in the 7MM [2019-2032]
• Risk-specific Incident Cases of FL in the 7MM [2019-2032]
• Transplant eligible and ineligible patient pool of FL in the 7MM [2019-2032]
• Stage-specific Incident Cases of FL in the 7MM [2019-2032]
• Mutation-specific Incident Cases of FL in the 7MM [2019-2032]
• Refractory/Relapsed Incident Cases of FL in the 7MM [2019-2032]

Get Key Insights Into the Evolving Follicular Lymphoma Epidemiology Trends @
https://www.delveinsight.com/report-store/follicular-lymphoma-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Follicular Lymphoma Drugs Uptake and Pipeline Development Activities
The drugs' uptake section focuses on the rate of uptake of the potential drugs recently launched in the Follicular Lymphoma market or expected to be launched during the study period. The analysis covers the market share by Follicular Lymphoma drugs, patient uptake by therapies, and sales of each drug.

The report's drugs uptake section helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It allows the comparison of the drugs based on market share and size, which again will be helpful in investigating factors important in understanding the market dynamics and in making financial and regulatory decisions.

The report also covers the Follicular Lymphoma Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Explore More About Ongoing Pipeline Development Activities @
https://www.delveinsight.com/sample-request/follicular-lymphoma-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Follicular Lymphoma Therapeutics Assessment
There are various treatment options for FL based on the severity of associated symptoms and the rate of cancer growth. If patients show no or very few symptoms, physicians recommend not to treat the disease right away-an approach referred to as active surveillance ("watch and wait").

The treatment of FL includes CAR T cell therapies, chemotherapy, radiation therapy, immunotherapy, and stem cell transplant. Patients with early-stage FL (Ann Arbor stages I or II) may be treated with radiation therapy alone or with radiation plus chemotherapy.

Several major pharma and biotech companies are developing therapies for Follicular Lymphoma. Few of the companies have their Follicular Lymphoma drug candidates in the most advanced stage of clinical development expected to enter the market in the near future.

Leading Companies in the Follicular Lymphoma Therapeutics Market Include
• Incyte Corporation
• Genmab A/S
• BeiGene
• Merck & Co.
• ADC Therapeutics
• Xynomic Pharmaceuticals
• Nordic Nanovector
• TG Therapeutics Inc
• Allogene Therapeutics
• MEI Pharma
• Innovent Biologics
And many others

Emerging and Marketed Follicular Lymphoma Therapies Covered in the Report Include
• Tafasitamab: Incyte Corporation
• Epcoritamab: Genmab A/S
• Zanubrutinib - BeiGene
• Pembrolizumab: Merck & Co.
• Monjuvi/Tafasitamab: Incyte Corporation/MorphoSys
• Breyanzi/JCAR017: Bristol Myers
And many more

Learn More About the Emerging Therapies & Key Companies in the Follicular Lymphoma Therapeutics Market:
https://www.delveinsight.com/sample-request/follicular-lymphoma-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Follicular Lymphoma Competitive Intelligence Analysis
4. Follicular Lymphoma Market Overview at a Glance
5. Follicular Lymphoma Background and Overview
6. Follicular Lymphoma Patient Journey
7. Follicular Lymphoma Epidemiology and Patient Population
8. Follicular Lymphoma Treatment Algorithm, Current Treatment, and Medical Practices
9. Follicular Lymphoma Unmet Needs
10. Key Endpoints of Follicular Lymphoma Treatment
11. Follicular Lymphoma Marketed Products
12. Follicular Lymphoma Emerging Therapies
13. Follicular Lymphoma Seven Major Market Analysis
14. Attribute Analysis
15. Follicular Lymphoma Market Outlook (7 major markets)
16. Follicular Lymphoma Access and Reimbursement Overview
17. KOL Views on the Follicular Lymphoma Market.
18. Follicular Lymphoma Market Drivers
19. Follicular Lymphoma Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.

Download the Sample PDF to Get Detailed Insights About the Report's Offerings @
https://www.delveinsight.com/sample-request/follicular-lymphoma-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

--------------------------------------------------------------------------------------------
Healthcare Consulting and Competitive Intelligence Services by DelveInsight
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research

Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices

Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology

--------------------------------------------------------------------------------------------
Other Trending Healthcare Reports by DelveInsight
Functional Electrical Stimulation (FES) Devices Market
https://www.delveinsight.com/report-store/functional-electrical-stimulation-fes-devices-market

Hypoactive Sexual Desire Disorder Market
https://www.delveinsight.com/report-store/hypoactive-sexual-desire-disorder-hsdd-market

Complicated Intra-Abdominal Infections Market
https://www.delveinsight.com/report-store/complicated-intra-abdominal-infections-market

Malignant Pleural Mesothelioma (MPM) Market
https://www.delveinsight.com/report-store/malignant-pleural-mesothelioma-market

Mitochondrial Myopathies Market
https://www.delveinsight.com/report-store/mitochondrial-myopathies-market

Asthma Diagnostic Devices Market
https://www.delveinsight.com/report-store/asthma-diagnostic-devices-market

Mayus Kinase (jak) Inhibitors Market
https://www.delveinsight.com/report-store/mayus-kinase-inhibitors-market

Acute Heart Failure Market
https://www.delveinsight.com/report-store/acute-heart-failure-ahf-market

Bacterial Vaginosis Market
https://www.delveinsight.com/report-store/bacterial-vaginosis-market

Hyperphosphatemia Market
https://www.delveinsight.com/report-store/hyperphosphatemia-market

Pleural Effusion Market
https://www.delveinsight.com/report-store/pleural-effusion-market

Epidermolysis Bullosa Market
https://www.delveinsight.com/report-store/epidermolysis-bullosa-market

Gestational Diabetes Market
https://www.delveinsight.com/report-store/gestational-diabetes-market

Intratumoral Cancer Therapies Market
https://www.delveinsight.com/report-store/intratumoral-cancer-therapies-market

Wasting Syndrome Market
https://www.delveinsight.com/report-store/wasting-syndrome-market

Parkinson's Disease Related Dementia Market
https://www.delveinsight.com/report-store/parkinsons-disease-related-dementia-market

Vagus Nerve Stimulator (VNS) Global Market
https://www.delveinsight.com/report-store/vagus-nerve-stimulator-market

Abetalipoproteinemia Market
https://www.delveinsight.com/report-store/abetalipoproteinemia-market

Myelofibrosis (MF) Market
https://www.delveinsight.com/report-store/myelofibrosis-mf-market

Chemotherapy Induced Neutropenia (CIN) Market
https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market

Homozygous Familial Hypercholesterolemia Market
https://www.delveinsight.com/report-store/homozygous-familial-hypercholesterolemia-market

Partial Onset seizures Market
https://www.delveinsight.com/report-store/partial-onset-seizures-market

West Nile Encephalitis Market
https://www.delveinsight.com/report-store/west-nile-encephalitis-market

Gonorrhea Market
https://www.delveinsight.com/report-store/gonorrhea-market

Polymyositis Market
https://www.delveinsight.com/report-store/polymyositis-market

Subarachnoid Hemorrhage Market
https://www.delveinsight.com/report-store/subarachnoid-hemorrhage-market

Acute Pancreatitis Market
https://www.delveinsight.com/report-store/acute-pancreatitis-market

Acute Respiratory Distress Syndrome (ARDS) Market
https://www.delveinsight.com/report-store/acute-respiratory-distress-syndrome-ards-market

Hypercoagulability Market
https://www.delveinsight.com/report-store/hypercoagulability-market

PARP Inhibitors Market
https://www.delveinsight.com/report-store/parp-inhibitors-competitive-landscape-pipeline-and-market-analysis

Bacterial Conjunctivitis Market
https://www.delveinsight.com/report-store/bacterial-conjunctivitis-market

Desmoplastic Small Round Cell Tumors (DSRCTS) Market
https://www.delveinsight.com/report-store/desmoplastic-small-round-cell-tumors-market

Hemophilia with Inhibitor Market
https://www.delveinsight.com/report-store/hemophilia-with-inhibitor-market

Pelvic Inflammatory Disease Market
https://www.delveinsight.com/report-store/pelvic-inflammatory-disease-market

Hemorrhoids Market
https://www.delveinsight.com/report-store/hemorrhoids-market

PCSK9 Inhibitors Market
https://www.delveinsight.com/report-store/pcsk9-inhibitors-market

Stargardt Disease (STGD) Market
https://www.delveinsight.com/report-store/stargardt-disease-stgd-market

Dravet Syndrome Market
https://www.delveinsight.com/report-store/dravet-syndrome-market

Genital Warts Market
https://www.delveinsight.com/report-store/genital-warts-condyloma-acuminatum-market

Orthopedic Trauma Devices Market
https://www.delveinsight.com/report-store/orthopedic-trauma-devices-market

Acute Lymphoblastic Leukemia (ALL) Market
https://www.delveinsight.com/report-store/acute-lymphoblastic-leukemia-all-market

Erythema Market
https://www.delveinsight.com/report-store/erythema-market

Primary Open Angle Glaucoma (POAG) Market
https://www.delveinsight.com/report-store/primary-open-angle-glaucoma-poag-market

Cutaneous Lupus Erythematosus Market
https://www.delveinsight.com/report-store/cutaneous-lupus-erythematosus-cle-market

Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Market
https://www.delveinsight.com/report-store/hospital-acquired-and-ventilator-associated-bacterial-pneumonia-market

Traumatic Brain Injury Assessment Devices Market
https://www.delveinsight.com/report-store/traumatic-brain-injury-assessment-management-devices-market

Cartilage Diseases Market
https://www.delveinsight.com/report-store/cartilage-diseases-market

Hormone Sensitive Advanced Prostate Cancer Market
https://www.delveinsight.com/report-store/hormone-sensitive-advanced-prostate-cancer-market

Neuromodulation Devices Global Market
https://www.delveinsight.com/report-store/neuromodulation-devices-market

Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.